Colin ORourke
Overview
Explore the profile of Colin ORourke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
633
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tee S, Hughes H, Ryan E, McCann J, ORourke C, Bourke M, et al.
Can Assoc Radiol J
. 2024 Sep;
76(2):333-343.
PMID: 39344072
Image-guided tumour ablation is a minimally invasive treatment for early stage hepatocellular carcinoma (HCC). Our study reviews the complications and long term outcomes in patients treated at a tertiary referral...
2.
Pribitzer S, ORourke C, Ylescupidez A, Smithmyer M, Bender C, Speake C, et al.
J Clin Endocrinol Metab
. 2024 May;
109(12):3211-3219.
PMID: 38712386
Background: Essentially all individuals with multiple autoantibodies will develop clinical type 1 diabetes. Multiple autoantibodies (AABs) and normal glucose tolerance define stage 1 diabetes; abnormal glucose tolerance defines stage 2....
3.
A standardized metric to enhance clinical trial design and outcome interpretation in type 1 diabetes
Ylescupidez A, Bahnson H, ORourke C, Lord S, Speake C, Greenbaum C
Nat Commun
. 2023 Nov;
14(1):7214.
PMID: 37940642
The use of a standardized outcome metric enhances clinical trial interpretation and cross-trial comparison. If a disease course is predictable, comparing modeled predictions with outcome data affords the precision and...
4.
Kwok M, Evans E, Hemmings O, Marknell DeWitt A, ORourke C, Bahnson H, et al.
J Allergy Clin Immunol Pract
. 2023 Jul;
11(11):3485-3492.e2.
PMID: 37495080
Background: A precise diagnosis of peanut allergy is extremely important. We identified 4 Ara h 2 peptides that improved Ara h 2-specific IgE (sIgE) diagnostic accuracy. Objective: To assess the...
5.
ORourke C, McKee H, Wijeyaratnam D, Bajwa J, Tremblay L, David E
Can Assoc Radiol J
. 2023 Apr;
74(4):745-754.
PMID: 37026571
Purpose: Retrospective review of splenic artery embolization (SAE) outcomes performed for blunt abdominal trauma. Materials And Methods: 11-year retrospective review at a large level-1 Canadian trauma centre. All patients who...
6.
Roberts G, Bahnson H, Du Toit G, ORourke C, Sever M, Brittain E, et al.
J Allergy Clin Immunol
. 2022 Dec;
151(5):1329-1336.
PMID: 36521802
Background: Peanut allergy affects 1% to 2% of European children. Early introduction of peanut into the diet reduces allergy in high-risk infants. Objective: We aimed to determine the optimal target...
7.
ORourke C, Ylescupidez A, Bahnson H, Bender C, Speake C, Lord S, et al.
J Clin Endocrinol Metab
. 2022 Oct;
108(3):688-696.
PMID: 36227635
Context: The presence of islet autoimmunity identifies individuals likely to progress to clinical type 1 diabetes (T1D). In clinical research studies, autoantibody screening followed by regular metabolic monitoring every 6...
8.
Kennecke H, Bahnson H, Lin B, ORourke C, Kaplan J, Pham H, et al.
JAMA Oncol
. 2022 Aug;
8(10):1466-1470.
PMID: 35980607
Importance: This study quantifies the trends in trimodality therapy use and its association with pathologic stage and overall survival of patients with rectal cancer at the population level. Objective: To...
9.
Bajzik V, DeBerg H, Garabatos N, Rust B, Obrien K, Nguyen Q, et al.
Allergy
. 2022 Mar;
77(8):2534-2548.
PMID: 35266148
Background: The PALISADE study, an international, phase 3 trial of peanut oral immunotherapy (POIT) with AR101, resulted in desensitization in children and adolescents who were highly allergic to peanut. An...
10.
So M, ORourke C, Ylescupidez A, Bahnson H, Steck A, Wentworth J, et al.
Diabetologia
. 2022 Jan;
65(4):684-694.
PMID: 35041021
Aims/hypothesis: Age is known to be one of the most important stratifiers of disease progression in type 1 diabetes. However, what drives the difference in rate of progression between adults...